Homepage
Medication Guide
How Effective is Anagrelide (Agrylin) in Treatment?
Anagrelide (Agrylin) is a drug specifically used for the treatment of thrombocythemia, and is particularly suitable for secondary thrombocythemia associated with myeloproliferative neoplasms.How Effec...
507
Tuesday, September 23rd, 2025, 13:27
Indications for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (Truvada)
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (Truvada) is a fixed-dose combination preparation used for the treatment and prevention of human immunodeficiency virus type 1 (HIV-1) infection...
513
Monday, September 22nd, 2025, 17:42
How to Use Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (Truvada)
Emtricitabine and Tenofovir Disoproxil Fumarate Tablets (Truvada) is a fixed-dose combination preparation for the treatment of HIV-1 infection, containing two active ingredients: emtricitabine (FTC) a...
510
Monday, September 22nd, 2025, 17:40
Indications for Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a small-molecule inhibitor targeting the MET kinase, developed by Novartis and granted accelerated approval by the U.S. FDA in 2020. As a precision therapeutic, it has de...
511
Monday, September 22nd, 2025, 16:46
Indications for Anagrelide (Agrylin)
Anagrelide (Agrylin) is a thrombocytopenic agent primarily used for the treatment of thrombocythemia caused by myeloproliferative neoplasms.Indications for Anagrelide (Agrylin)Reducing Elevated Platel...
508
Monday, September 22nd, 2025, 16:28
Precautions for Anagrelide (Agrylin) Administration
Anagrelide (Agrylin) is a thrombocytopenic agent primarily used for the treatment of thrombocythemia secondary to myeloproliferative neoplasms. It can reduce platelet count, lower the risk of thrombos...
510
Monday, September 22nd, 2025, 16:16
How to Use Anagrelide (Agrylin)
Anagrelide (Agrylin) is a selective antiplatelet agent primarily used for the treatment of thrombocythemia secondary to myeloproliferative neoplasms. It reduces the risk of thrombosis and improves rel...
511
Monday, September 22nd, 2025, 15:59
What Are the Side Effects of Camatinib (Tabrecta)?
Camatinib (Tabrecta) is a targeted MET kinase inhibitor indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations. As a ...
506
Monday, September 22nd, 2025, 15:50
How Effective is Camatinib (Tabrecta) in Treatment?
Camatinib (Tabrecta) is a targeted therapeutic drug that has shown good efficacy in the treatment of specific types of non-small cell lung cancer (NSCLC) in recent years. As a kinase inhibitor, it exe...
509
Monday, September 22nd, 2025, 15:46
Precautions for Camatinib (Tabrecta) Administration
Camatinib (Tabrecta) is a kinase inhibitor targeting metastatic non-small cell lung cancer (NSCLC) with METex14 skipping mutation. Its efficacy has been verified in clinical trials. However, during th...
511
Monday, September 22nd, 2025, 15:42
109 / 208
2071 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved